Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Pharmacokinetic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05180890
What this trial is testing

Danavorexton (TAK-925) in Adults With Obstructive Sleep Apnea

Who this might be right for
Sleep Apnea
Takeda 13
Testing effectiveness (Phase 2)WithdrawnNCT02064010
What this trial is testing

Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia

Who this might be right for
Drug-induced Tardive Dyskinesia
Synchroneuron Inc.
Testing effectiveness (Phase 2)Study completedNCT00044915
What this trial is testing

Repinotan in Patients With Acute Ischemic Stroke

Who this might be right for
StrokeAcute Ischemic Stroke
Bayer 782
Early research (Phase 1)Study completedNCT00621725
What this trial is testing

Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours

Who this might be right for
Advanced CancerHepatic Impairment
AstraZeneca 36
Early research (Phase 1)Looking for participantsNCT06210815
What this trial is testing

HLX42 in Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumor and NSCLC
Shanghai Henlius Biotech 102
Testing effectiveness (Phase 2)Ended earlyNCT00505089
What this trial is testing

Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Novartis 11
Early research (Phase 1)Ended earlyNCT05740280
What this trial is testing

ICP-NI - Safety, Tolerability, Pharmacokinetic, and Immunogenicity Study in Healthy Male and Female Subjects

Who this might be right for
Healthy Volunteers
Cellivery Therapeutics, Inc. 24
Early research (Phase 1)Study completedNCT06824948
What this trial is testing

Evaluate the Safety, Tolerance, and Pharmacokinetic Profiles of Timolol Maleate Gel

Who this might be right for
Healthy Subjects
Auson Pharmaceuticals Inc. 28
Early research (Phase 1)Study completedNCT03075410
What this trial is testing

First Time in Human (FTIH) Safety and Pharmacokinetics (PK) Study of GSK3036656 in Healthy Subjects

Who this might be right for
Tuberculosis
GlaxoSmithKline 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07841925
What this trial is testing

BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 30
Early research (Phase 1)UnknownNCT04441918
What this trial is testing

Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects

Who this might be right for
COVID-19; and High Infection Risk of SARS-CoV-2
Shanghai Junshi Bioscience Co., Ltd. 40
Early research (Phase 1)UnknownNCT06273813
What this trial is testing

Treatment of Topical Ketorolac Gel in Acute Gouty Flare

Who this might be right for
Acute Gouty ArthritisAcute PainGout Flare
Novilla Pharmaceuticals 30
Testing effectiveness (Phase 2)Ended earlyNCT03819218
What this trial is testing

A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent Subjects

Who this might be right for
Psoriasis Vulgaris
MC2 Therapeutics 7
Testing effectiveness (Phase 2)Study completedNCT01918397
What this trial is testing

Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB

Who this might be right for
Tuberculosis, Multidrug-Resistant
Boston University 111
Very early researchNot Yet RecruitingNCT07420010
What this trial is testing

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

Who this might be right for
Ovarian CancerMesotheliomaColon Cancer
Weijia Fang, MD 24
Early research (Phase 1)Study completedNCT00416962
What this trial is testing

Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine

Who this might be right for
Healthy
Novartis 18
Testing effectiveness (Phase 2)Ended earlyNCT00206661
What this trial is testing

Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease

Who this might be right for
Crohn Disease
Genzyme, a Sanofi Company 22
Early research (Phase 1)Study completedNCT02134964
What this trial is testing

Phase 1 Safety and PK Study of OLT1177 Capsules

Who this might be right for
Healthy Volunteers
Olatec Therapeutics, Inc. 35
Early research (Phase 1)Active Not RecruitingNCT05385692
What this trial is testing

BL-M02D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors or Other Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Digestive Tract TumorsSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 22
Early research (Phase 1)Study completedNCT01901198
What this trial is testing

Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase I Study in Chinese Healthy Volunteers

Who this might be right for
Healthy Volunteers
Beijing Bio-Fortune Ltd. 34
Next Page